(Q30658418)

26 June 2017

title

HPLC and GC-MS screening of Chinese proprietary medicine for undeclared therapeutic substances (English)

1 reference

26 June 2017

Liu SY

1

1 reference

26 June 2017

Woo SO

series ordinal

2

1 reference

26 June 2017

Koh HL

series ordinal

3

1 reference

26 June 2017

publication date

1 March 2001

1 reference

Journal of Pharmaceutical and Biomedical Analysis

26 June 2017

published in

1 reference

26 June 2017

volume

24

1 reference

26 June 2017

issue

5-6

1 reference

26 June 2017

page(s)

983-992

1 reference

Chinese herbal medicines revisited: a Hong Kong perspective

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900571-9

7 January 2021

Monitoring the safety of Chinese herbal medicines in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900571-9

7 January 2021

Fatal accidental aconitine poisoning following ingestion of Chinese herbal medicine: a report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900571-9

7 January 2021

Chinese herbal medicine: camouflaged prescription antiinflammatory drugs, corticosteroids, and lead

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900571-9

7 January 2021

Complications resulting from the use of Chinese herbal medications containing undeclared prescription drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900571-9

7 January 2021

Chinese herbal medicine induced acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900571-9

7 January 2021

Usage and adverse effects of Chinese herbal medicines

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900571-9

7 January 2021

Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900571-9

7 January 2021

Traditional oriental medicines. I. Black pearl: identification and chromatographic determination of some undeclared medicinal ingredients

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900571-9

7 January 2021

Identification of prescription drugs in adulterated Chinese herbal medications

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900571-9

7 January 2021

Use of high-performance liquid chromatography with photodiode-array UV detection for the creation of a 600-compound library. Application to forensic toxicology

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900571-9

7 January 2021

Reversed-phase high-performance liquid chromatography-photodiode-array analysis of alkaloid drugs of forensic interest

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900571-9

7 January 2021

Applications of an HPLC-DAD drug-screening system based on retention indices and UV spectra

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900571-9

7 January 2021

Comparison of algorithms and databases for matching unknown mass spectra.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900571-9

7 January 2021

LC and LC-MS-MS analyses of undeclared codeine in antiasthmatic Chinese proprietary medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900571-9

7 January 2021

Chinese proprietary medicine in Singapore: regulatory control of toxic heavy metals and undeclared drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900571-9

7 January 2021

10.1016/S0731-7085(00)00571-9

Identifiers

DOI

1 reference

26 June 2017

1 reference